Fusion protein for screening and evaluating anti-enterovirus 71 medicine and application of fusion protein
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- HARBIN MEDICAL UNIVERSITY
- Publication Date
- 2012-11-07
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a fusion protein for screening and evaluating drugs and its application, in particular to a fusion protein for screening and evaluating anti-EV71 drugs based on a chemiluminescence method and its application. Belongs to the field of biotechnology. Background technique
[0002] Enterovirus 71 (enterovirus 71, EV71) is an important neuroinfectious enterovirus, and currently there is no effective treatment and vaccine. There are reports of outbreaks of infectious diseases associated with EV71 virus infection in the Asia-Pacific region and around the world (AbuBakar, S., et al.. Enterovirus71 outbreak, Brunei. Emerg. Infect. Dis. 2009, 15:79-82.) . EV71 infection mainly causes a rash in children known as hand-foot-mouth disease (HFMD). However, acute infection with EV71 can also cause severe neurological disease and high mortality. In particular, EV71 infection in children under five years of age has been associated with neurol...